These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Influence of lymphokines on the anti-TNP-Ficoll response of normal and X-linked B lymphocyte-defective mice. Author: Xue B, Bell MK, Thorbecke GJ. Journal: J Immunol; 1983 Oct; 131(4):1698-701. PubMed ID: 6352801. Abstract: Immunodeficient CBA/N and F1 hybrids of CBA/N X SJL or DBA/2Ha mice were induced to make an antibody response to TNP-Ficoll by i.v. injections of lymphokines together with the antigen. The best responses (up to 12,000 PFC/spleen on day 4) were obtained by repeated i.v. lymphokine injections on days 0, 1, 2, and 3. Lymphokines obtained from PHA-stimulated LBRM-33 cells were less effective than those in supernatants (SN) from cocultures of SJL lymph node and gamma-RCS lymphoma cells, although in each case 100 U IL 2 were given per injection. Similar SN injections caused two- to threefold increases in responses of nondefective F1 hybrids. Pretreatment with lymphokine before TNP-Ficoll injection had no effect. Additional injection of monoclonal anti-IgD decreased the effect of lymphokine. Responses to TNP-Ficoll of CBA/J spleen cells were enhanced in vitro by SN as shown previously. Although responses by CBA/N spleen cells to TNP-polyacrylamide were increased by SN, however, responses to TNP-Ficoll could not be obtained with spleen cells from the xid mice in vitro.[Abstract] [Full Text] [Related] [New Search]